This campaign has now closed

Inherited retinal conditions are the most common cause of blindness in the working age population of the UK. Last year the first gene therapy for one of these conditions was approved for use on the NHS. This brings real hope; but the COVID-19 pandemic has slowed progress - we must regain momentum.

100%
Categories

  • Health/Wellbeing Health/​Wellbeing
  • Medical Research Medical Research
  • Beneficiaries

    • People With Disabilities People With Disabilities

    Situation

    People with inherited sight loss face unique challenges, as they live not only with visual impairment, but also with the knowledge of its inevitable onset and deterioration. Losing your sight can lead to depression, anxiety, social isolation and reduced quality of life, as well as difficulties with finding employment. We aim to do all we can to make these challenges a thing of the past. Medical research into treatments is crucial and we must regain the momentum lost during the COVD-19 pandemic.

    Solution

    We will carefully invest the funds raised into the most promising medical research projects currently taking place. Our selective approach aims to achieve the maximum amount of progress, and the emergence of the very first treatment from the clinical trials pipeline last year evidences the fact that this approach works. We also aim to support researchers with cost extensions where their work has been impacted by COVID-19.

    • “”
      -
    • “”
      -
    100%
    Categories

  • Health/Wellbeing Health/​Wellbeing
  • Medical Research Medical Research
  • Beneficiaries

    • People With Disabilities People With Disabilities